Brain Tumor Drugs Global Market 2022 Opportunities And Strategies To 2030: COVID-19 Impact And Recovery Including: By Drugs: (Temozolomide; Carmustine; Cisplatin; Bevacizumab; Geftinib; Erlotinib); By End User: Hospital Pharmacies; Clinics
- Report ID: 43111
- Date: Sep, 2022
- Pages: 261
- Category: Healthcare & Pharmaceuticals
Brain Tumor Drugs Global Market Opportunities And Strategies To 2030: COVID-19 Impact And Recovery from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global brain tumor drugs market as it emerges from the COVID 19 shut down.
This report describes and explains the global brain tumor drugs market and covers 2015 to 2020, termed the historic period, and 2020 to 2025 termed the forecast period, along with further forecasts for the period 2025-2030. The report evaluates the market across each region and for the major economies within each region.
The global brain tumor drugs market reached a value of nearly $5,656.4 million in 2020, having increased at a compound annual growth rate (CAGR) of 12.5% since 2015. The market is expected to grow from $5,656.4 million in 2020 to $9,128.1 million in 2025 at a rate of 10%. The market is then expected to grow at a CAGR of 8.8% from 2025 and reach $13,932 million in 2030.
Growth in the historic period in the brain tumor drugs market resulted increasing prevalence of neurological disorders, increased healthcare expenditure, increased number of approvals for oncology (cancer) drugs, increase in pharmaceutical R&D expenditure, and advances in cancer drug discovery. The market was restrained increasing use of targeted therapies, pricing pressures from regulators, challenges due to regulatory changes, and low healthcare access.
Going forward, increase in cancer incidence rate, rise in healthcare expenditure, increasing geriatric population, strong pipeline of drugs, and revised FDA regulations to facilitate biologics drug development. Factors that could hinder the growth of the market in the future include high costs of drugs, rise in interest rates, rising popularity of alternative therapies and natural remedies, and coronavirus pandemic.
The brain tumor drugs market is segmented by drugs into temozolomide, bevacizumab, and others. The others was the largest segment of the brain tumor drugs market segmented by drugs, accounting for 69.3% of the total in 2020. Going forward, the Temozolomide segment is expected to be the fastest growing segment in the brain tumor drugs market segmented by drugs, at a CAGR of 15.2% during 2020-2025.
The brain tumor drugs market is also segmented by end-user into hospital pharmacies, retail pharmacies and other end-users. The hospital pharmacies market was the largest segment of the brain tumor drugs market segmented by end-user, accounting for 53.4% of the total in 2020. Going forward, the other end-users segment is expected to be the fastest growing segment in the brain tumor drugs market segmented by end-user, at a CAGR of 11.1% during 2020-2025.
Asia Pacific was the largest region in the brain tumor drugs market, accounting for 31.8% of the total in 2020. It was followed by the North America, Western Europe and then the other regions. Going forward, the fastest-growing regions in the brain tumor drugs market will be Asia Pacific and Western Europe where growth will be at CAGRs of 11.8% and 9.9% respectively during 2020-2025. These will be followed by South America and North America, where the markets are expected to register CAGRs of 9.4% and 9.1% respectively during 2020-2025.
The global brain tumor drugs market is fragmented, with a large number of players. The top ten competitors in the market made up to 28.1% of the total market in 2020. Major players in the market include F. Hoffmann-La Roche Ltd, Novartis AG, Amgen Inc., Pfizer Inc., and Merck & Co. Inc.
The top opportunities in the brain tumor drugs market segmented by drugs will arise in the others segment, which will gain $2,494.7 million of global annual sales by 2025. The top opportunities in the brain tumor drugs market segmented by end-user will arise in hospital pharmacies segment, which will gain $1,804.9 million of global annual sales by 2025.
Market-trend-based strategies for the brain tumor drugs includes investing in combination of drugs for brain tumor treatment, adapting the use of phase zero clinical trials to improve efficacy, use of technology for drug delivery that improves the efficacy of the drug, focus on the expansion of cell and gene therapy, and carrying out strategic mergers and acquisitions.
Player-adopted strategies in the brain tumor drugs market include focusing on new product development, strategic collaborations, expanding business presence in developed and emerging regions, strategic acquisitions and agreements, and strengthening their product portfolio by new drug approvals.
To take advantage of the opportunities, The Business Research Company recommends the brain tumor companies to focus on combination of drugs to help with treatment, adopt phase zero clinical trials, focus on nanotechnology for drug delivery and tumor treatment, focus on expansion of cell and gene therapy & CAR-T for brain tumors, expanding in emerging markets, set up authorized distributors and sales representatives, bundled payments, skimmed pricing, adopt premium pricing, participate in trade shows and events, increase visibility through business websites and listing websites, use big data analytics to improve marketing activities, targeting hospitals and pharmacies to spread awareness, and targeting the geriatric population.
Reasons to Purchase
• Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for brain tumor drugs? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The brain tumor drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider brain tumor drugs market; and compares it with other markets.
The report covers the following chapters
1. Executive Summary – The executive summary section of the report gives a brief overview and summary of the report
2. Report Structure – This section gives the structure of the report and the information covered in the various sections.
3. Introduction – The introduction section of the report gives brief introduction about segmentation by drugs, and segmentation by end-user.
4. Market Characteristics – The market characteristics section of the report defines and explains brain tumor drugs market. This chapter also defines and describes goods and related services covered in the report.
5.
Trends And Strategies – This chapter describes the major trends shaping the global brain tumor drugs market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
6. Impact of COVID-19 – This section describes the impact of COVID-19 on the brain tumor drugs market.
7.
Global Market Size And Growth – This section contains the global historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
8.
Regional Analysis – This section contains the historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values and growth and market share comparison by region.
9.
Segmentation – This section contains the market values (2015-2030) and analysis for different segments.
10. Global Macro Comparison – The global brain tumor drugs market comparison with macro-economic factors gives the brain tumor drugs market size, percentage of GDP, and average brain tumor drugs market expenditure.
Regional Market Size and Growth – This section contains the region’s market size (2020), historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
12.
Competitive Landscape – This section covers details on the competitive landscape of the global brain tumor drugs market, estimated market shares and company profiles for the leading players.
CordenPharma
Eisai Co., Ltd.
Emcure Pharmaceuticals Limited
AstraZeneca
Y-mAbs Therapeutics
Roche India
Novartis Oncology
Arlak Biotech
Healthkind labs Pvt. Ltd.
SwisscheM Healthcare Pvt.Ltd
Apikos Pharma
Kolaz biotech.
CStone Pharma
CARsgen Therapeutics
JW Therapeutics
BeiGene
Takeda Pharmaceuticals
Astellas Pharma Inc
Otsuka Pharmaceutical Co., Ltd
Daiichi Pharmaceutical and Sankyo
AQVIDA GmbH
Baxter International Inc
AstraZeneca plc
GlaxoSmithKline plc
F. Hoffmann-La Roche AG
Veropharm
Biocad
Roche
Bristol-Myers Squibb
Celon Pharma
Celgene Corporation
Johnson & Johnson
F. Hoffmann-La Roche Ltd
Eli Lilly and Company
Merck
Pfizer
Amgen
AstraZeneca
Bayer AG
Novartis AG
Sandoz AG (A Novartis Division)
Eurofarma Laboratórios S.A.
GlaxoSmithKline plc
TUTEUR Argentina
The Takeda Pharmaceutical Company Limited
Pierre Fabre Group
Celnova Pharma
Pfizer S.R.L.
Johnson & Johnson
Teva Pharmaceutical Industries Ltd.
BIOPHARMA-MEA
NeoTX
AID Genomics Limited
Novartis AG
GlaxoSmithKline plc
Pfizer
Merck Sharp & Dohme Corp. (Merck & Co., Inc.)
Julphar
Sanofi
Bayer
Kitov Pharma Limited
CureTech Ltd.
Neopharma
Eurolab
Aspen
Adcock Ingram
Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
.
Market Opportunities And Strategies – This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
Conclusions And Recommendations – This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for brain tumor drug companies in terms of product offerings, geographic expansion, marketing strategies and target groups.
Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Scope
Markets Covered:
1) By Drugs: Temozolomide; Carmustine; Cisplatin; Bevacizumab; Geftinib; Erlotinib
2) By End User: Hospital Pharmacies; Clinics; Others
Companies Mentioned: F. Hoffmann-La Roche Ltd.; Novartis AG; Amgen Inc.; Pfizer Inc.; Merck & Co. Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; brain tumor drugs indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
1. Brain Tumor Drugs Market Executive Summary
2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
6. Introduction
6.1. Segmentation By Geography
7. Brain Tumor Drugs Market Characteristics
7.1. Market Definition
7.2. Market Segmentation By Drugs
7.2.1. Temozolomide
7.2.2. Bevacizumab
7.2.3. Others
7.3. Market Segmentation By End-User
7.3.1. Hospital Pharmacies
7.3.2. Retail Pharmacies/Drug Stores
7.3.3. Other Pharmacies
8. Brain Tumor Drugs Market Trends And Strategies
8.1. Combination Of Drugs To Help With Treatment
8.2. Adapting Phase Zero Clinical Trials
8.3. Nanotechnology For Drug Delivery And Tumor Treatment
8.4. Expansion Of Cell And Gene Therapy & CAR-T For Brain Tumors
8.5. Increasing Mergers And Acquisitions
9. Impact Of COVID-19 On Brain Tumor Drugs Market
9.1. Clinical Trial Delays
9.2. Low Usage Of Drugs
9.3. Supply Chain Issues
9.4. Shortage In Resources
9.5. Impact on Patients
9.6. Future Outlook
10. Global Brain Tumor Drugs Market Size And Growth
10.1. Market Size
10.2. Historic Market Growth, 2015 – 2020, Value ($ Million)
10.2.1. Drivers Of The Market 2015 – 2020
10.2.2. Restraints On The Market 2015 – 2020
10.3. Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
10.3.1. Drivers Of The Market 2020 – 2025
10.3.2. Restraints On The Market 2020 – 2025
11. Global Brain Tumor Drugs Market Segmentation
11.1. Global Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
11.2. Global Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
12. Brain Tumor Drugs Market, Regional And Country Analysis
12.1. Global Brain Tumor Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
12.2. Global Brain Tumor Drugs Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13. Asia-Pacific Brain Tumor Drugs Market
13.1. Asia-Pacific Brain Tumor Drugs Market Overview
13.1.1. Region Information
13.1.2. Impact Of COVID-19
13.1.3. Market Information
13.1.4. Background Information
13.1.5. New Drug Approvals
13.1.6. Government Initiatives
13.1.7. Regulations
13.1.8. Regulatory Bodies
13.1.9. Major Associations
13.1.10. Taxes Levied
13.1.11. Corporate Tax Structure
13.1.12. Investment
13.1.13. Major Companies
13.2. Asia-Pacific Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
13.3. Asia-Pacific Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
13.4. Asia-Pacific Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.5. Asia-Pacific Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.6. Asia-Pacific Brain Tumor Drugs Market: Country Analysis
13.7. China Brain Tumor Drugs Market
13.8. China Brain Tumor Drugs Market Overview
13.8.1. Country Information
13.8.2. Impact Of COVID-19
13.8.3. Market Information
13.8.4. Background Information
13.8.5. New Drug Approvals
13.8.6. Government Initiatives
13.8.7. Regulations
13.8.8. Regulatory Bodies
13.8.9. Major Associations
13.8.10. Taxes Levied
13.8.11. Corporate Tax Structure
13.8.12. Investment
13.8.13. Major Companies
13.9. China Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
13.10. China Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
13.11. China Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.12. China Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.13. India Brain Tumor Drugs Market
13.14. India Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
13.15. India Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
13.16. India Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.17. India Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.18. Japan Brain Tumor Drugs Market
13.19. Japan Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
13.20. Japan Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
13.21. Japan Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.22. Japan Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.23. Australia Brain Tumor Drugs Market
13.24. Australia Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
13.25. Australia Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
13.26. Australia Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.27. Australia Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.28. Indonesia Brain Tumor Drugs Market
13.29. Indonesia Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
13.30. Indonesia Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
13.31. Indonesia Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.32. Indonesia Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.33. South Korea Brain Tumor Drugs Market
13.34. South Korea Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
13.35. South Korea Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
13.36. South Korea Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
13.37. South Korea Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
14. Western Europe Brain Tumor Drugs Market
14.1. Western Europe Brain Tumor Drugs Market Overview
14.1.1. Region Information
14.1.2. Impact Of COVID-19
14.1.3. Market Information
14.1.4. Background Information
14.1.5. New Drug Approvals
14.1.6. Government Initiatives
14.1.7. Regulations
14.1.8. Regulatory Bodies
14.1.9. Major Associations
14.1.10. Taxes Levied
14.1.11. Corporate Tax Structure
14.1.12. Investment
14.1.13. Major Companies
14.2. Western Europe Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
14.3. Western Europe Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
14.4. Western Europe Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
14.5. Western Europe Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
14.6. Western Europe Brain Tumor Drugs Market: Country Analysis
14.7. UK Brain Tumor Drugs Market
14.8. UK Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
14.9. UK Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
14.10. UK Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
14.11. UK Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
14.12. Germany Brain Tumor Drugs Market
14.13. Germany Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
14.14. Germany Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
14.15. Germany Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
14.16. Germany Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
14.17. France Brain Tumor Drugs Market
14.18. France Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
14.19. France Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
14.20. France Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
14.21. France Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
15. Eastern Europe Brain Tumor Drugs Market
15.1. Eastern Europe Brain Tumor Drugs Market Overview
15.1.1. Region Information
15.1.2. Impact Of COVID-19
15.1.3. Market Information
15.1.4. Background Information
15.1.5. Government Initiatives
15.1.6. Regulations
15.1.7. Regulatory Bodies
15.1.8. Major Associations
15.1.9. Taxes Levied
15.1.10. Corporate Tax Structure
15.1.11. Investments
15.1.12. Major Companies
15.2. Eastern Europe Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
15.3. Eastern Europe Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
15.4. Eastern Europe Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
15.5. Eastern Europe Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
15.6. Eastern Europe Brain Tumor Drugs Market: Country Analysis
15.7. Russia Brain Tumor Drugs Market
15.8. Russia Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
15.9. Russia Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
15.10. Russia Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
15.11. Russia Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
16. North America Brain Tumor Drugs Market
16.1. North America Brain Tumor Drugs Market Overview
16.1.1. Region Information
16.1.2. Impact Of COVID-19
16.1.3. Market Information
16.1.4. Background Information
16.1.5. New Drug Approvals
16.1.6. Government Initiatives
16.1.7. Regulations
16.1.8. Regulatory Bodies
16.1.9. Major Associations
16.1.10. Taxes Levied
16.1.11. Corporate Tax Structure
16.1.12. Investments
16.1.13. Major Companies
16.2. North America Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
16.3. North America Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
16.4. North America Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
16.5. North America Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
16.6. North America Brain Tumor Drugs Market: Country Analysis
16.7. USA Brain Tumor Drugs Market
16.8. USA Brain Tumor Drugs Market Overview
16.8.1. Country Information
16.8.2. Impact Of COVID-19
16.8.3. Market Information
16.8.4. Background Information
16.8.5. New Drug Approvals
16.8.6. Government Initiatives
16.8.7. Regulations
16.8.8. Regulatory Bodies
16.8.9. Major Associations
16.8.10. Corporate Tax Structure
16.8.11. Investments
16.8.12. Major Companies
16.9. USA Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
16.10. USA Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
16.11. USA Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
16.12. USA Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
17. South America Brain Tumor Drugs Market
17.1. South America Brain Tumor Drugs Market Overview
17.1.1. Region Information
17.1.2. Impact Of COVID-19
17.1.3. Market Information
17.1.4. Background Information
17.1.5. Government Initiatives
17.1.6. Regulations
17.1.7. Regulatory Bodies
17.1.8. Major Associations
17.1.9. Taxes Levied
17.1.10. Corporate Tax Structure
17.1.11. Investments
17.1.12. Major Companies
17.2. South America Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
17.3. South America Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
17.4. South America Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
17.5. South America Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
17.6. South America Brain Tumor Drugs Market: Country Analysis
17.7. Brazil Brain Tumor Drugs Market
17.8. Brazil Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
17.9. Brazil Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
17.10. Brazil Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
17.11. Brazil Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
18. Middle East Brain Tumor Drugs Market
18.1. Middle East Brain Tumor Drugs Market Overview
18.1.1. Region Information
18.1.2. Impact Of COVID-19
18.1.3. Market Information
18.1.4. Background Information
18.1.5. New Drug Approvals
18.1.6. Government Initiatives
18.1.7. Regulations
18.1.8. Regulatory Bodies
18.1.9. Major Associations
18.1.10. Taxes Levied
18.1.11. Corporate Tax Structure
18.1.12. Investments
18.1.13. Major Companies
18.2. Middle East Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
18.3. Middle East Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
18.4. Middle East Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
18.5. Middle East Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
19. Africa Brain Tumor Drugs Market
19.1. Africa Brain Tumor Drugs Market Overview
19.1.1. Region Information
19.1.2. Impact Of COVID-19
19.1.3. Market Information
19.1.4. Background Information
19.1.5. Government Initiatives
19.1.6. Regulations
19.1.7. Regulatory Bodies
19.1.8. Major Associations
19.1.9. Taxes Levied
19.1.10. Corporate Tax Structure
19.1.11. Investments
19.1.12. Major Companies
19.2. Africa Brain Tumor Drugs Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
19.3. Africa Brain Tumor Drugs Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
19.4. Africa Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
19.5. Africa Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
20. Brain Tumor Drugs Global Market Competitive Landscape
20.1. Company Profiles
20.2. F. Hoffmann-La Roche Ltd
20.2.1. Company Overview
20.2.2. Products And Services
20.2.3. Business Strategy
20.2.4. Financial Overview
20.3. Novartis AG
20.3.1. Company Overview
20.3.2. Products And Services
20.3.3. Business Strategy
20.3.4. Financial Overview
20.4. Amgen Inc.
20.4.1. Company Overview
20.4.2. Products And Services
20.4.3. Business Strategy
20.4.4. Financial Overview
20.5. Pfizer Inc.
20.5.1. Company Overview
20.5.2. Products And Services
20.5.3. Business Strategy
20.5.4. Financial Overview
20.6. Merck & Co., Inc.
20.6.1. Company Overview
20.6.2. Products And Services
20.6.3. Business Strategy
20.6.4. Financial Overview
21. Brain Tumor Drugs Pipeline Analysis
22. Key Mergers And Acquisitions In The Brain Tumor Drugs Market
22.1. Pfizer To Acquire Trillium Therapeutics INC.
22.2. Chimerix Acquired Oncoceutics
22.3. Century Therapeutics Acquired Empirica Therapeutics
22.4. Kintara Therapeutics Merged With Adgero Biopharmaceuticals
22.5. CNS Pharmaceuticals Acquired Houston Pharmaceuticals
22.6. TRIGR Therapeutics Collaborated With ABL Bio
23. Global Brain Tumor Drugs Market Opportunities And Strategies
23.1. Global Brain Tumor Drugs Market In 2025 – Countries Offering Most New Opportunities
23.2. Global Brain Tumor Drugs Market In 2025 – Segments Offering Most New Opportunities
23.3. Global Brain Tumor Drugs Market In 2025 – Growth Strategies
23.3.1. Market Trend Based Strategies
23.3.2. Competitor Strategies
24. Appendix
24.1. Market Data Sources
24.2. Research Methodology
24.3. Currencies
24.4. Research Inquiries
24.5. The Business Research Company
24.6. Copyright and Disclaimer
List of Tables
Table 1: Global Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Table 2: Global Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Table 3: Global Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 4: Global Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 5: Global Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 6: Global Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 7: Global Brain Tumor Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
Table 8: Global Brain Tumor Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 9: Global Brain Tumor Drugs Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
Table 10: Global Brain Tumor Drugs Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 11: Asia-Pacific Vaccine Market, COVID-19 Vaccines Approvals
Table 12: Asia-Pacific Vaccine Market, Number of COVID-19 Doses Administered, By Country
Table 13: Asia-Pacific, Population By Age Group, By Country, 2015-2025, Thousands
Table 14: Asia-Pacific Brain Tumor Drugs Market , Per Capita Healthcare Expenditure, By Country, 2015-2019, $
Table 15: Asia-Pacific, Oncology Drugs Market Size, By Country, 2015-2025, $ Billion
Table 16: Asia-Pacific, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
Table 17: Asia-Pacific Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Table 18: Asia-Pacific Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Table 19: Asia-Pacific Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 20: Asia-Pacific Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 21: Asia-Pacific Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 22: Asia-Pacific Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 23: China Vaccine Market, COVID-19 Vaccines Approvals
Table 24: China, Population By Age Group, 2015-2025, Thousands
Table 25: China Brain Tumor Drugs Market, Per Capita Healthcare Expenditure, 2015-2019, $
Table 26: China, Oncology Drugs Market Size, By Country, 2015-2025, $ Billion
Table 27: China, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
Table 28: China Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Table 29: China Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Table 30: China Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 31: China Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 32: China Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 33: China Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 34: India Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Table 35: India Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Table 36: India Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 37: India Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 38: India Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 39: India Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 40: Japan Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Table 41: Japan Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Table 42: Japan Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 43: Japan Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 44: Japan Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 45: Japan Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 46: Australia Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Table 47: Australia Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Table 48: Australia Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 49: Australia Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 50: Australia Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 51: Australia Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 52: Indonesia Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Table 53: Indonesia Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Table 54: Indonesia Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 55: Indonesia Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 56: Indonesia Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 57: Indonesia Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 58: South Korea Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Table 59: South Korea Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Table 60: South Korea Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 61: South Korea Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 62: South Korea Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 63: South Korea Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 64: Western Europe Vaccine Market, COVID-19 Vaccines Approvals
Table 65: Western Europe Vaccine Market, Number of COVID-19 Doses Administered, By Country
Table 66: Western Europe, Population By Age Group, By Country, 2015-2025, Thousands
Table 67: Western Europe Brain Tumor Drugs Market, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
Table 68: Western Europe, Oncology Drugs Market Size, By Country, 2015-2025, $ Billion
Table 69: Western Europe, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
Table 70: Western Europe Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Table 71: Western Europe Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Table 72: Western Europe Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 73: Western Europe Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 74: Western Europe Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 75: Western Europe Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 76: UK Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Table 77: UK Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Table 78: UK Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 79: UK Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 80: UK Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 81: UK Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 82: Germany Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Table 83: Germany Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Table 84: Germany Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 85: Germany Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 86: Germany Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 87: Germany Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 88: France Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Table 89: France Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Table 90: France Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 91: France Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 92: France Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 93: France Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 94: Western Europe Vaccine Market, COVID-19 Vaccines Approvals
Table 95: Eastern Europe Vaccine Market, Number of COVID-19 Doses Administered, By Country
Table 96: Eastern Europe, Population By Age Group, By Country, 2015-2025, Thousands
Table 97: Eastern Europe Brain Tumor Drugs Market, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
Table 98: Eastern Europe, Oncology Drugs Market Size, By Country, 2015-2025, $ Billion
Table 99: Eastern Europe, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
Table 100: Eastern Europe Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Table 101: Eastern Europe Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Table 102: Eastern Europe Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 103: Eastern Europe Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 104: Eastern Europe Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 105: Eastern Europe Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 106: Russia Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Table 107: Russia Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Table 108: Russia Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 109: Russia Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 110: Russia Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 111: Russia Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 112: North America Vaccine Market, COVID-19 Vaccines Approvals
Table 113: North America Vaccine Market, Number of COVID-19 Doses Administered, By Country
Table 114: North America, Population By Age Group, By Country, 2015-2025, Thousands
Table 115: North America Brain Tumor Drugs Market, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
Table 116: North America, Oncology Drugs Market Size, By Country, 2015-2025, $ Billion
Table 117: North America, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
Table 118: North America Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Table 119: North America Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Table 120: North America Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 121: North America Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 122: North America Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 123: North America Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 124: USA Vaccine Market, COVID-19 Vaccines Approvals
Table 125: USA, Population By Age Group, 2015-2025, Thousands
Table 126: USA Brain Tumor Drugs Market, Per Capita Healthcare Expenditure, 2015-2019, $
Table 127: USA Home, Oncology Drugs Market Size, By Country, 2015-2025, $ Billion
Table 128: USA Home, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
Table 129: USA Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Table 130: USA Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Table 131: USA Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 132: USA Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 133: USA Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 134: USA Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 135: South America Vaccine Market, COVID-19 Vaccines Approvals
Table 136: South America Vaccine Market, Number of COVID-19 Doses Administered, By Country
Table 137: South America, Population By Age Group, By Country, 2015-2025, Thousands
Table 138: South America Brain Tumor Drugs Market, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
Table 139: South America, Oncology Drugs Market Size, By Country, 2015-2025, $ Billion
Table 140: South America, Healthcare Services Market Size, By Country, 2015-2025, $ Billion
Table 141: South America Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Table 142: South America Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Table 143: South America Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 144: South America Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 145: South America Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 146: South America Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 147: Brazil Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Table 148: Brazil Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Table 149: Brazil Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 150: Brazil Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 151: Brazil Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 152: Brazil Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 153: Middle East Vaccine Market, COVID-19 Vaccines Approvals
Table 154: Middle East Vaccine Market, Number of COVID-19 Doses Administered, By Country
Table 155: Middle East, Population By Age Group, By Country, 2015-2025, Thousands
Table 156: Middle East Brain Tumor Drugs Market, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
Table 157: Middle East Oncology Drugs Market Size, By Country, 2015-2025, $ Billion
Table 158: Middle East Healthcare Services Market Size, By Country, 2015-2025, $ Billion
Table 159: Middle East Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Table 160: Middle East Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Table 161: Middle East Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 162: Middle East Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 163: Middle East Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 164: Middle East Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 165: Africa Vaccine Market, COVID-19 Vaccines Approvals
Table 166: Middle East Vaccine Market, Number of COVID-19 Doses Administered, By Country
Table 167: Africa, Population By Age Group, By Country, 2015-2025, Thousands
Table 168: Africa Brain Tumor Drugs Market, Per Capita Healthcare Expenditure, By Country, 2015-2019, $
Table 169: Africa Oncology Drugs Market Size, By Country, 2015-2025, $ Billion
Table 170: Africa Healthcare Services Market Size, By Country, 2015-2025, $ Billion
Table 171: Africa Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Table 172: Africa Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Table 173: Africa Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 174: Africa Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 175: Africa Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Table 176: Africa Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
Table 177: Global Brain Tumor Drugs Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
Table 178: F. Hoffmann-La Roche Ltd – Financial Overview, 2016 - 2020, $ Billion
Table 179: Novartis AG – Financial Performance, 2016 – 2020, $ Billion
Table 180: Amgen Inc. – Financial Performance, 2016 – 2020, $ Billion
Table 181: Pfizer Inc. – Financial Overview, 2016 - 2020, $ Billion
Table 182: Merck & Co., Inc. – Financial Performance, 2016 - 2020, $ Billion
Table 183: Global Brain Tumor Drugs Market, Pipeline Analysis
Table 184: Global Brain Tumor Drugs Market Size Gain ($ Million), 2020 – 2025, By Country
Table 185: Global Brain Tumor Drugs Market Size Gain ($ Million), Segmentation By Drugs, 2020 – 2025
Table 186: Global Brain Tumor Drugs Market Size Gain ($ Million), Segmentation By End-User, 2020 – 2025
Table 187: Brain Tumor Drugs- Market Data Sources
List of Figures
Figure 1: Global Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Figure 2: Global Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Figure 3: Global Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 4: Global Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 5: Global Brain Tumor Drugs Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 6: Global Brain Tumor Drugs Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 7: Asia-Pacific Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Figure 8: Asia-Pacific Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Figure 9: Asia-Pacific Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 10: Asia-Pacific Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 11: China Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Figure 12: China Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Figure 13: China Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 14: China Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 15: India Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Figure 16: India Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Figure 17: India Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 18: India Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 19: Japan Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Figure 20: Japan Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Figure 21: Japan Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 22: Japan Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 23: Australia Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Figure 24: Australia Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Figure 25: Australia Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 26: Australia Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 27: Indonesia Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Figure 28: Indonesia Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Figure 29: Indonesia Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 30: Indonesia Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 31: South Korea Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Figure 32: South Korea Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Figure 33: South Korea Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 34: South Korea Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 35: Western Europe Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Figure 36: Western Europe Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Figure 37: Western Europe Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 38: Western Europe Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 39: UK Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Figure 40: UK Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Figure 41: UK Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 42: UK Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 43: Germany Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Figure 44: Germany Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Figure 45: Germany Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 46: Germany Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 47: France Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Figure 48: France Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Figure 49: France Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 50: France Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 51: Eastern Europe Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Figure 52: Eastern Europe Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Figure 53: Eastern Europe Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 54: Eastern Europe Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 55: Russia Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Figure 56: Russia Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Figure 57: Russia Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 58: Russia Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 59: North America Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Figure 60: North America Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Figure 61: North America Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 62: North America Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 63: USA Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Figure 64: USA Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Figure 65: USA Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 66: USA Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 67: South America Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Figure 68: South America Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Figure 69: South America Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 70: South America Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 71: Brazil Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Figure 72: Brazil Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Figure 73: Brazil Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 74: Brazil Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 75: Middle East Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Figure 76: Middle East Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Figure 77: Middle East Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 78: Middle East Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 79: Africa Brain Tumor Drugs Market, Historic, 2015 – 2020, $ Million
Figure 80: Africa Brain Tumor Drugs Market, Forecast, 2020 – 2025, 2030F, $ Million
Figure 81: Africa Brain Tumor Drugs Market, Segmentation By Drugs, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 82: Africa Brain Tumor Drugs Market, Segmentation By End-User, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
Figure 83: Global Brain Tumor Drugs Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
Figure 84: F. Hoffmann-La Roche Ltd – Financial Overview, 2016 – 2020, $ Billion
Figure 85: Novartis AG – Financial Performance, 2016 – 2020, $ Billion
Figure 86: Amgen Inc. – Financial Performance, 2016 – 2020, $ Billion
Figure 87: Pfizer Inc. – Financial Overview, 2016 – 2020, $ Billion
Figure 88: Merck & Co., Inc. – Financial Performance, 2016-2020, $ Billion
Research methodology is mainly referring to the practical how of any offered piece of research. More specifically, it’s all about how a researcher systematically designs a study in order to assure extremely valid as well as reliable results that ultimately address the targets and objectives of the research.
In any formal research including academic journal, article, dissertation and so on, there will be a special section on a research methodology that mainly describes what, by whom, how to gather as well as how to evaluate the data are provided.
This research methodology has been segmented into following types:
Primary Research:
It is said to be original information that the researchers collect for the crucial purposes of answering the research questions of readers with the help of surveys, observations and experiments.
Secondary Research:
The secondary research is the data that has already been collected by various other researchers in the form of government analysis or scientific studies.
Qualitative Research:
It is descriptive and subjective method irrespective of facts. Both observation and description are essential in this type of research methodology. Its main vision is to analyze knowledge, attitudes, behaviours as well as opinions of people related to the topic of any research. This method has been operated through grounded research, case study and actionable research.
Quantitative Research:
It contains several laboratory experiments, basic surveys, mathematical calculations, simulations and so on. The possible measurement, quantity or amount is considered to be a major factor in the quantitative research methodology.
Clients
